Avaxia Biologics, Inc. Raises $2.2 Million in First Closing of Series A Financing to Advance Oral Antibodies for Inflammatory Bow... ( LEXINGTON Mass. Nov. 10 2011 /- a hre...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> BIOLOGY >> TECHNOLOGY

Avaxia Biologics, Inc. Raises $2.2 Million in First Closing of Series A Financing to Advance Oral Antibodies for Inflammatory Bowel Disease

Date:11/10/2011

LEXINGTON, Mass., Nov. 10, 2011 /PRNewswire/ -- Avaxia Biologics, Inc., a privately-held biotech company developing oral antibody drugs that act locally within the gastrointestinal tract, announced today that the company completed its first close of $2.2 million of a Series A angel-led financing. Cherrystone Angels of Providence, Rhode Island led the round, with participation from Boston Harbor Angels and other undisclosed individuals. Mr. Robert Manning, the co-Chairman of Cherrystone Angels, will join the Avaxia board. Mr. Manning has served as a senior executive at Citigroup and on a number of early-stage company boards, including SmartCells.

Dr. Barbara Fox, Avaxia's founder and CEO, commented, "This investment will allow us to aggressively pursue the development of our AVX-470 anti-TNF oral antibody and prepare Avaxia to initiate a clinical trial in inflammatory bowel disease next fall. When coupled with the funding we have received from BARDA (Biomedical Advanced Research and Development Authority) to develop AVX-470 for GI Acute Radiation Syndrome, our investors have a unique opportunity to participate in the rapid creation of value in two important disease areas. We are in advanced discussions with a limited number of other qualified investors as we work to complete this planned round of financing. The angel community's response to Avaxia has been very gratifying."

The funds from this financing will be used to manufacture drug to be used in the clinical trial and to conduct final pre-clinical studies in advance of a Phase 1b clinical trial in patients with inflammatory bowel disease, being planned for the second half of 2012. The company has raised $4.3 million in non-dilutive financing prior to this equity round. In addition to a loan from the Massachusetts Life Sciences Center and several SBIR grants, the company was awarded a $2.9 million, 2-year contract with BARDA that fully funds the initi
'/>"/>

SOURCE Avaxia Biologics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. Avaxia Biologics Awarded Phase I SBIR Grant to Develop Antibody Therapeutic for Oral Mucositis
2. Dr. Lester Mandelker to Collaborate with Nuovo Biologics, LLC
3. Oncobiologics, Inc. to Unveil New Biologics Proof-of-Concept Engine at BIO International Convention
4. Reportlinker Adds Biotechnology Industry 2010 Yearbook - Top Biologics, Biosimilars, Licensing and Financing, Mergers and Acquisitions
5. ImaginAb, Inc. and BZL Biologics, LLC Conclude Licensing Agreement for Imaging Rights to huJ591/Prostate-Specific Membrane Antigen (PSMA)
6. LaVoie Group Adds Bio-Surgery Company, Pegasus Biologics, to Its Life Sciences Agency Roster
7. DLVR Therapeutics Inc. Raises Additional Capital Adding MaRS Innovation to Investor Base
8. Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies
9. Dyadic International Raises $3 Million in Private Placement of Convertible Notes
10. Creabilis Raises €15M ($20M) in Series B Fundraising Round
11. SironRX Therapeutics Raises $3.4 Million Series A

Post Your Comments:

(Date:6/14/2013)... 2013 Stem cells have long been touted as the ... to Dr. Dennis Lox , some patients with a ... to stem cell therapy for aid. Avascular necrosis (AVN) also ... in which the blood supply to the bone becomes disrupted, ... to as necrosis. The region may be very painful, and ...

(Date:6/14/2013)... DIEGO , June 14, 2013 Mast Therapeutics, ... an underwritten public offering of 50,000,000 units, each unit ... common stock and one warrant to purchase 0.5 of ... price of $0.50 per unit. The units will not ... stock and the warrants are immediately separable and will ...

(Date:6/14/2013)... Toronto, ON / Boston, MA (PRWEB) June 14, ... the world’s largest independent resource for life scientists ... new e-commerce features within the growing 1DegreeBio marketplace. ... quickly browse through hundreds of vendor catalogues, access ... create purchase orders, email products to lab managers ...

(Date:6/13/2013)... Eagle Biosciences is proud to announce ... Calprotectin ELISA assay kit that offers the ... µg/g stool). The Calprotectin ELISA assay kit is ... Calprotectin (neutrophil cytoplasmic protein s100A8/A9, MRP 8/14) in ... assay line which already includes Alpha 1 Antitrypsin ...

Breaking Biology Technology:Stem Cells May Help Some With Avascular Necrosis (AVN) 2 Mast Therapeutics Prices Public Offering Of Units 2 Mast Therapeutics Prices Public Offering Of Units 3 Mast Therapeutics Prices Public Offering Of Units 4 1DegreeBio Inc. Boosts Review-Driven Reagent Marketplace with New e-Commerce Platform 2 Eagle Biosciences Introduces Highly Sensitive Calprotectin ELISA Assay Kit 2

[0] Stem Cells May Help Some With Avascular Necrosis (AVN)[0] Mast Therapeutics Prices Public Offering Of Units [0] 1DegreeBio Inc. Boosts Review-Driven Reagent Marketplace with New e-Commerce Platform [0] Eagle Biosciences Introduces Highly Sensitive Calprotectin ELISA Assay Kit

... hardest substance in the human body is moved by its ... a schnitzel, enormous strengths are working on the surface of ... also goes for dentures, inlays or bridges", glass chemist Prof. ... (Germany) says. After all, these are worn as much as ...

... 2012 Tengion, Inc. (NASDAQ: TNGN ... it has completed the relocation of its corporate ... existing facility in Winston-Salem, North Carolina. The relocation ... which was designed to fund the Company,s lead ...

... Jan. 5, 2012 Superior Controls, Inc. has been ... Control Engineering magazine. Each year, the worldwide competition ... exceptional technical expertise, business skills and customer satisfaction. ... 50 applications from industrial systems integrators throughout the ...

Cached Biology Technology:Nanocrystals make dentures shine 2 Tengion Announces Relocation of Corporate Headquarters to Current Facility in Winston-Salem, North Carolina 2 Tengion Announces Relocation of Corporate Headquarters to Current Facility in Winston-Salem, North Carolina 3 Tengion Announces Relocation of Corporate Headquarters to Current Facility in Winston-Salem, North Carolina 4 Superior Controls of Seabrook, NH Named System Integrator of the Year for 2012 by Control Engineering Magazine 2

Nanocrystals make dentures shine Tengion Announces Relocation of Corporate Headquarters to Current Facility in Winston-Salem, North Carolina Superior Controls of Seabrook, NH Named System Integrator of the Year for 2012 by Control Engineering Magazine

(Date:6/17/2013)... patients with severe brain infections in Vietnam. Further research ... for the symptoms of disease. , The virus was ... patients with severe brain infections in the study, corresponding ... 122 patients with non-infectious brain disorders that were tested. ... are often fatal and patients who do survive, often ...

(Date:6/17/2013)... foundations with more modern elements. Using this same approachbut ... Dietrich School of Arts and Sciences have designed a ... storage, and gas transport more efficient and at a ... issue of the Journal of the American Chemical ... builds upon Pitt Associate Professor of Chemistry Nathaniel Rosi,s ...

(Date:6/17/2013)... 2013) The AGA Research Foundation and Horizon Pharma ... of gastroenterology with the 2013 AGA-Horizon Pharma Fellow Abstract ... , "In its third year, this competition continues to ... on promising careers in basic and clinical research," said ... Research Foundation. "We are extremely proud of all that ...

Breaking Biology News(10 mins):New virus isolated from patients with severe brain infections 2 New virus isolated from patients with severe brain infections 3 'Chemical architects' build materials with potential applications in drug delivery and gas storage 2 Horizon Pharma Abstract Prizes recognize promising fellows and students 2

[0] New virus isolated from patients with severe brain infections [0] 'Chemical architects' build materials with potential applications in drug delivery and gas storage [0] Horizon Pharma Abstract Prizes recognize promising fellows and students

... from the University of Exeter has revealed taking a dietary ... boost stamina during high-intensity exercise. The study has important ... can allow people to exercise up to 20% longer and ... comes on the back of previous research from Exeter which ...

... such as depression, anxiety disorders, addiction and schizophrenia are ... the world. In the EU alone, each year 27% ... 83 Million citizens suffer from mental disorders. Depression ... as the most disabling disorder of all diseases. Unless ...

... Nev. There is still much that is unknown ... Reno psychologist has added to the body of knowledge ... to demystify, prevent and treat the mysterious condition. ... assistant professor of psychology at the University of Nevada, ...

Supplement produces a 'striking' endurance boost 23rd ECNP Congress: Pioneering CNS research -- translating neuroscience into clinical progress University of Nevada professor studies structural basis for autism disorders

384 well block MBSr. Robot compatible block ejection mechanism. Stackable. (384 well block - holds 384 well plate)...

...

Buckets for 2 racks of 5 tubes, type Stago/Hitachi...

... The MBS Satellite Thermal ... and flexible solution for medium ... The MBS combines the latest ... friendly software and PC control, ...

Biology Products:

Robotic MBS Thermal Cycler 384 Well from Thermo Scientific Cable (20 mtrs) from Thermo Scientific Buckets for 2 racks of 5 tubes, type Stago/Hitachi from Thermo Scientific MBS Satellite Thermal Cycler from Thermo Scientific